Pure Global

ATELLICA IM ANTI-THYROGLOBULIN II (ATGII) - INVIMA Registration d19a790cbcc467b1c21df1b81ee58ea7

Access comprehensive regulatory information for ATELLICA IM ANTI-THYROGLOBULIN II (ATGII) (ATELLICA IM ANTI-THYROGLOBULIN II (ATGII)) in the Colombia medical device market through Pure Global AI's free database. This medical device is registered under INVIMA analysis ID d19a790cbcc467b1c21df1b81ee58ea7 and manufactured by SIEMENS HEALTHCARE SAS. The device was registered on January 29, 2031.

This page provides complete registration details including product type (DIAGNOSTIC REAGENT), authorised information, and regulatory compliance data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.

Free Database
Powered by Pure Global AI
INVIMA Official Data
d19a790cbcc467b1c21df1b81ee58ea7
ATELLICA IM ANTI-THYROGLOBULIN II (ATGII)
INVIMA Analysis ID: d19a790cbcc467b1c21df1b81ee58ea7
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Device Classification
Product Type (Spanish)
REACTIVO DIAGNOSTICO
Product Type (English)
DIAGNOSTIC REAGENT
Registration Information
Analysis ID
d19a790cbcc467b1c21df1b81ee58ea7
Expire Date
January 29, 2031
Authorized Company / Fabricante
Name (English)
SIEMENS HEALTHCARE SAS